Skip to main content

Table 2 Effects of first greater occipital nerve injection in 159 chronic headache patients with available follow-up

From: Treatment of disabling headache with greater occipital nerve injections in a large population of childhood and adolescent patients: a service evaluation

Improvement from injection

n = 105 P < 0.001

66%

Duration of improvement (weeks)

9.3 ± 4.3

 

Benefit per HA diagnosis (n; %)

 CM

70

69%

 CMwA

15

63%

 Total migraine

85

68%

 NDPH

13

59%

 CH

3

100%

 HC

0

0%

 SUNCT/SUNA

1

50%

 Total TAC

4

67%

 TTH

1

100%

 Secondary HA

2

50%

Sustained HA freedom (>3 weeks)

17

16%

 CM

11

16%

 CMwA

2 (one brainstem)

13%

 Total migraine

13

10% of total migraine

 NDPH

2

15%, 9% of total NDPH

 CH

1

33%

 SUNCT

1

100%

 Total TAC

2

33% of total TAC

Side effects

13

8%

Worsened HA int/freq for up to 5 weeks

6 (with no improvement)

 

Worsened HA int/freq for up to 10 days

5 (with improvement)

 

Soreness

1

 

Reaction to sedative

1